PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD
Visit https://www.peervoice.com/JHP860 to view the entire programme with slides. After completing “Claus Vogelmeier, MD - Approaching Airway Inflammation From Another Angle: The Rationale for Targeting Type 2 Pathways in COPD”, participants will be able to: Identify current unmet needs in the achievement of goals of care in patients with chronic obstructive pulmonary disease (COPD); Describe the role of type 2 inflammation in the pathophysiology of COPD; and Evaluate emerging efficacy and safety data for the use of biologic therapies in the treatment of COPD.